Advertisement
Advertisement
U.S. markets open in 7 hours 52 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Mindset Pharma Inc. (MSET.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.89000.0000 (0.00%)
At close: 03:57PM EST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.8900
Open0.0000
Bid0.8800 x N/A
Ask0.8900 x N/A
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume162,913
Market Cap78.172M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.2240
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.98
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for MSET.CN

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • ACCESSWIRE

      The Power Play by The Market Herald Interviews James Lanthier of Mindset Pharma

      VANCOUVER, BC / ACCESSWIRE / January 5, 2022 / The Power Play by The Market Herald has announced the release of a new interview with Mindset Pharma on their latest news.The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

    • CNW Group

      IIROC Trade Resumption - MSET

      Trading resumes in:

    • GlobeNewswire

      The McQuade Center for Strategic Research and Development and Mindset Pharma Collaborate to Develop Psychedelic Medicines

      PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- The McQuade Center for Strategic Research and Development, LLC (MSRD), a member of the global Otsuka family of pharmaceutical companies, and Mindset Pharma Inc. (Mindset) (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) today announce a collaboration that will support the development of psychedelic medicines. MSRD has made a strategic investment to support the discovery and development of novel chemical entity assets of Mindset, a drug discovery and develo

    Advertisement
    Advertisement